OCUGEN, INC. Increase (Decrease) in Accounts Payable
OCUGEN, INC. (OCGN) reported Increase (Decrease) in Accounts Payable of -$1.05 million for the 6-month period ending 2019-06-30, per its 10-Q filed 2019-08-09.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2019-08-09
- OCUGEN, INC. increase (decrease) in accounts payable for the quarter ending 2019-06-30 was -$560.00K, a 166.27% decline year-over-year.
- OCUGEN, INC. increase (decrease) in accounts payable for the quarter ending 2019-03-31 was -$491.00K, a 183.79% decline year-over-year.
- OCUGEN, INC. increase (decrease) in accounts payable for the quarter ending 2018-12-31 was -$172.00K.
- OCUGEN, INC. increase (decrease) in accounts payable for the quarter ending 2018-09-30 was -$570.00K.
- OCUGEN, INC. increase (decrease) in accounts payable for fiscal 2018 was $689.00K.
- OCUGEN, INC. increase (decrease) in accounts payable for fiscal 2017 was -$849.00K.
- OCUGEN, INC. increase (decrease) in accounts payable for fiscal 2016 was -$435.00K.
- OCUGEN, INC. increase (decrease) in accounts payable for fiscal 2015 was -$2.84M, a 240.38% decline from fiscal 2014.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 3 month as first filed | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 6 month as first filed | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 9 month as first filed | Increase (Decrease) in Accounts Payable 12 month | Increase (Decrease) in Accounts Payable 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2019-06-30 | -$560.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | -$1.05M 10-Q · filed 2019-08-09 | -$1.22M derived: sum of 3 quarters · filed 2019-08-09 | -$1.79M derived: sum of 4 quarters · filed 2019-08-09 | ||||
| 2019-03-31 | -$491.00K 10-Q · filed 2019-05-15 | -$663.00K derived: sum of 2 quarters · filed 2019-05-15 | -$1.23M derived: sum of 3 quarters · filed 2019-05-15 | -$388.00K derived: sum of 4 quarters · filed 2019-08-09 | ||||
| 2018-12-31 | -$172.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-22 | -$742.00K derived: sum of 2 quarters · filed 2019-03-22 | $103.00K derived: sum of 3 quarters · filed 2019-08-09 | $689.00K 10-K · filed 2019-03-22 | ||||
| 2018-09-30 | -$570.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $275.00K derived: sum of 2 quarters · filed 2019-08-09 | $861.00K 10-Q · filed 2018-11-08 | $773.00K derived: sum of 4 quarters · filed 2019-08-09 | ||||
| 2018-06-30 | $845.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $1.43M 10-Q · filed 2019-08-09 | $1.34M derived: sum of 3 quarters · filed 2019-08-09 | $552.00K derived: sum of 4 quarters · filed 2019-08-09 | ||||
| 2018-03-31 | $586.00K 10-Q · filed 2019-05-15 | $498.00K derived: sum of 2 quarters · filed 2019-05-15 | -$293.00K derived: sum of 3 quarters · filed 2019-05-15 | -$562.00K derived: sum of 4 quarters · filed 2019-05-15 | ||||
| 2017-12-31 | -$88.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-22 | -$879.00K derived: sum of 2 quarters · filed 2019-03-22 | -$1.15M derived: sum of 3 quarters · filed 2019-03-22 | -$849.00K 10-K · filed 2019-03-22 | ||||
| 2017-09-30 | -$791.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | -$1.06M derived: sum of 2 quarters · filed 2018-11-08 | -$761.00K 10-Q · filed 2018-11-08 | -$838.00K derived: sum of 4 quarters · filed 2018-11-08 | ||||
| 2017-06-30 | -$269.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $30.00K 10-Q · filed 2018-08-09 | -$47.00K derived: sum of 3 quarters · filed 2018-08-09 | -$150.00K derived: sum of 4 quarters · filed 2018-08-09 | ||||
| 2017-03-31 | $299.00K 10-Q · filed 2018-05-10 | $222.00K derived: sum of 2 quarters · filed 2018-05-10 | $119.00K derived: sum of 3 quarters · filed 2018-05-10 | $175.00K derived: sum of 4 quarters · filed 2018-05-10 | ||||
| 2016-12-31 | -$77.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | -$180.00K derived: sum of 2 quarters · filed 2018-03-15 | -$124.00K derived: sum of 3 quarters · filed 2018-03-15 | -$435.00K 10-K · filed 2018-03-15 | ||||
| 2016-09-30 | -$103.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | -$47.00K derived: sum of 2 quarters · filed 2017-11-09 | -$358.00K 10-Q · filed 2017-11-09 | -$63.00K derived: sum of 4 quarters · filed 2017-11-09 | ||||
| 2016-06-30 | $56.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10 | -$255.00K 10-Q · filed 2017-08-10 | $40.00K derived: sum of 3 quarters · filed 2017-08-10 | -$436.00K derived: sum of 4 quarters · filed 2017-08-10 | ||||
| 2016-03-31 | -$311.00K 10-Q · filed 2017-05-11 | -$16.00K derived: sum of 2 quarters · filed 2017-05-11 | -$492.00K derived: sum of 3 quarters · filed 2017-05-11 | -$1.34M derived: sum of 4 quarters · filed 2017-05-11 | ||||
| 2015-12-31 | $295.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | -$181.00K derived: sum of 2 quarters · filed 2017-03-16 | -$1.02M derived: sum of 3 quarters · filed 2017-03-16 | -$2.84M 10-K · filed 2017-03-16 | -$2.63M 10-K · filed 2016-03-10 | |||
| 2015-09-30 | -$476.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | -$1.32M derived: sum of 2 quarters · filed 2016-11-10 | -$3.14M 10-Q · filed 2016-11-10 | -$2.88M 10-Q · filed 2015-11-12 | -$3.11M derived: sum of 4 quarters · filed 2016-11-10 | |||
| 2015-06-30 | -$844.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11 | -$2.66M 10-Q · filed 2016-08-11 | -$2.55M 10-Q · filed 2015-08-12 | -$2.63M derived: sum of 3 quarters · filed 2016-08-11 | -$464.00K derived: sum of 4 quarters · filed 2016-08-11 | |||
| 2015-03-31 | -$1.82M 10-Q · filed 2016-05-12 | -$1.59M 10-Q · filed 2015-05-14 | -$1.79M derived: sum of 2 quarters · filed 2016-05-12 | $380.00K derived: sum of 3 quarters · filed 2016-05-12 | $173.00K derived: sum of 4 quarters · filed 2016-05-12 | |||
| 2014-12-31 | $33.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-10 | $2.20M derived: sum of 2 quarters · filed 2016-03-10 | $1.99M derived: sum of 3 quarters · filed 2016-03-10 | $2.03M 10-K · filed 2016-03-10 | ||||
| 2014-09-30 | $2.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | $1.96M derived: sum of 2 quarters · filed 2015-11-12 | $1.99M 10-Q · filed 2015-11-12 | |||||
| 2014-06-30 | -$207.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-12 | -$173.00K 10-Q · filed 2015-08-12 | ||||||
| 2014-03-31 | $34.00K 10-Q · filed 2015-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B |